Novonesis
Tue Micheelsen currently serves as President of North America and Head of Global Consumer Health at Novonesis, the largest bio-solutions company resulting from the merger of Novozymes and Christian Hansen. With significant experience in leadership positions within Novozymes since 2003, including roles such as Vice President of Consumer Biosolutions and Global Sales & Marketing for Household Care, Tue has a strong background in commercial operations across various regions, including Asia Pacific and Europe. Additionally, Tue is a board member of Novo Nordisk Pharmatech A/S, a leading biotech company specializing in pharmaceutical production technologies. Educational qualifications include advanced degrees from Copenhagen Business School and executive programs at Harvard Business School and INSEAD.
This person is not in any teams
This person is not in any offices
Novonesis
44 followers
At Novonesis, we believe solutions rooted in biology are key to tackling the challenges our world faces. Enzymes, functional proteins and microorganisms are our planet's tiniest, yet mightiest agents of change. When we leverage their power with science, we create biosolutions that transform the way we all produce, consume and live. Today, we are 10,000 people worldwide whose expertise spans more than 30 different industries. All around the world our biosolutions already create value for thousands of customers and benefit the planet. Our solutions enable feeding and fueling the world more sustainably, from healthy and sustainable nutrition to biofuel. Biosolutions also reduce the use of fossil-based resources, chemicals, energy and water. And this is just the beginning. The potential is almost endless. The time for biosolutions is now. And by working closely with our partners and customers, we will continue to challenge conventional thinking and transform business with biology. Together, we will create the change our world needs. Let’s better our world with biology.